Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
Lawrence Corey(Fred Hutch Cancer Center), Myron S. Cohen(University of North Carolina at Chapel Hill), Nyaradzo Mgodi(University of Zimbabwe), Michal Juraska(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Yunda Huang(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Glenda Gray(South African Medical Research Council), Srilatha Edupuganti(Emory University), James G. Kublin(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Estelle Piwowar‐Manning(Johns Hopkins University), Allan C. deCamp(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Nidhi Kochar(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Catherine Orrell(South African Medical Research Council), April K. Randhawa(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lynn Morris(National Health Laboratory Service), Simbarashe Takuva(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Carolyn Williamson(National Health Laboratory Service), Carter Bentley(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Nicole Espy(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Erika Rudnicki(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Nirupama Sista(Family Health International 360), Fatima Laher(University of the Witwatersrand), Margarita M. Gomez Lorenzo(Norwegian Womens Public Health Association), Joseph Makhema(Norwegian Womens Public Health Association), Pamela Mukwekwerere(University of Zimbabwe), Kyle Marshall(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Shelly Karuna(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Deborah Donnell(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Ian Frank(Norwegian Womens Public Health Association), Pedro Gonzáles(Hospital Nacional Dos de Mayo), John R. Mascola(National Institute of Allergy and Infectious Diseases), Erica Lazarus(Norwegian Womens Public Health Association), Julie E. Ledgerwood(Vaccine Research Institute of San Diego), M. Juliana McElrath(Fred Hutch Cancer Center), Peter B. Gilbert(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Magdalena E. Sobieszczyk(Columbia University Irving Medical Center), P. Andrew(Family Health International 360), Lindsey R. Baden(Brigham and Women's Hospital), Jorge Sánchez(National University of San Marcos), David Burns(Norwegian Womens Public Health Association), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Juan Hinojosa(Asociación para la Conservación de la Cuenca Amazónica), James I. Mullins(University of Washington), Javier R. Lama(Asociación Civil Impacta Salud y Educación), Robinson Cabello(Asociación Civil Impacta Salud y Educación), David C. Montefiori(Duke University)
Cited by 540
Related Papers
Integrated analysis of multimodal single-cell data
|Cell|2021|16.2k
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k